Back to Search Start Over

The LMCD1-AS1/miR-526b-3p/OSBPL5 axis promotes cell proliferation, migration and invasion in non-small cell lung cancer.

Authors :
Hu, Rui
Yu, Yankai
Wang, Haining
Source :
BMC Pulmonary Medicine; 1/9/2022, Vol. 22 Issue 1, p1-12, 12p
Publication Year :
2022

Abstract

<bold>Purpose: </bold>To explore the specific role and regulatory mechanism of oxysterol binding protein like 5 (OSBPL5) in non-small cell lung cancer (NSCLC).<bold>Methods and Results: </bold>Quantitative real-time polymerase chain reaction (qRT-PCR) analysis demonstrated that OSBPL5 expression was notably elevated in NSCLC tissues and cell lines, and Kaplan-Meier analysis manifested that high OSBPL5 expression was closely related to the poor prognosis of NSCLC patients. Besides, according to the results from western blot analysis, cell counting kit-8, EdU and Transwell assays, knockdown of OSBPL5 suppressed NSCLC cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process. Additionally, by performing qRT-PCR analysis, luciferase reporter and RNA pull-down assays, we verified that OSBPL5 was a downstream target of miR-526b-3p and long noncoding RNA (lncRNA) LMCD1-AS1 served as a sponge for miR-526b-3p. Moreover, from rescue assays, we observed that OSBPL5 overexpression offset LMCD1-AS1 knockdown-mediated inhibition in cell proliferation, migration, invasion and EMT in NSCLC.<bold>Conclusions: </bold>This paper was the first to probe the molecular regulatory mechanism of OSBPL5 involving the LMCD1-AS1/miR-526b-3p axis in NSCLC and our results revealed that the LMCD1-AS1/miR-526b-3p/OSBPL5 axis facilitates NSCLC cell proliferation, migration, invasion and EMT, which may offer a novel therapeutic direction for NSCLC. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712466
Volume :
22
Issue :
1
Database :
Complementary Index
Journal :
BMC Pulmonary Medicine
Publication Type :
Academic Journal
Accession number :
154567370
Full Text :
https://doi.org/10.1186/s12890-022-01820-7